| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $591.6M | +16.1% |
| Cost of Revenue | $347.0M | +7.8% |
| Gross Profit | $244.6M | +30.2% |
| R&D Expense | $27.3M | -9.9% |
| SG&A Expense | $243.1M | -0.1% |
| Operating Income | -$107.7M | +31.6% |
| Interest Expense | $6.9M | +358.6% |
| Pre-tax Income | -$97.1M | +39.1% |
| Income Tax | -$9.1M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $342.5M | +30.1% |
| Accounts Receivable | $131.2M | +9.6% |
| Inventory | $24.2M | -0.5% |
| Current Assets | $596.8M | -1.4% |
| Total Assets | $1.68B | -3.4% |
| Current Liabilities | $96.3M | +7.1% |
| Long-term Debt | $538.2M | +0.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.0M | +97.0% |
| Capital Expenditures | $28.8M | -6.9% |
| Investing Cash Flow | $76.7M | — |
| Financing Cash Flow | $4.6M | -61.5% |
| Free Cash Flow | -$30.7M | +68.3% |
| +39.5% |
| Net Income | -$88.0M | +39.0% |
| Total Liabilities |
| $739.7M |
| -0.3% |
| Stockholders' Equity | $941.5M | -5.7% |